Avid Bioservices Inc (CDMO)

[md1225]

You did not have to read further because you came to the same conclusion as everyone else?

Bavituximab is the clear leader in the immunotherapy race?

Bavituximab is void of the toxic side effects CTL-4, PD-1 and PD-L1 are associated with?

All immunotherapy drugs in development should be combined with Bavituximab to ensure patients receive the best possible clinical response and possible complete remission?

The true winner in the "Race For A Cure" will be the "medium pharma" that partners Peregrine?

CELG GILD BIIB ABBV ??? I hear it's not a big pharma. But what do I know?

Thanks for reading the article Dew! Part 2 will be the article of the year on Seeking Alpha!

Please take a moment and finish reading the whole article.

http://seekingalpha.com/article/1852541-the-race-for-a-cure-for-cancer